Search research articles
Contact Us
Filters
Showing results (151-160 of 396) with videos related to
Page
of 40
Sort By:
Human Psychopharmacology
|
October 2, 2007
Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrate
Thomas Roth, David Mayleben, Bruce C Corser, et al.
Sleep
|
December 2, 2011
Continuous positive airway pressure in severe obstructive sleep apnea reduces pain sensitivity
Imran Khalid, Timothy A Roehrs, David W Hudgel, et al.
The Clinical Journal of Pain
|
June 3, 2015
Pregabalin Improves Fibromyalgia-related Sleep Disturbance
Thomas Roth, Pritha Bhadra-Brown, Verne W Pitman, et al.
Human Psychopharmacology
|
December 15, 2019
Efficacy of SM-1 in a transient insomnia model
Thomas Dahl, Lan Bo Chen, Gary Zammit, et al.
Journal of Clinical Medicine
|
May 30, 2019
Sleep after Heavy Alcohol Consumption and Physical Activity Levels during Alcohol Hangover
Lydia E Devenney, Kieran B Coyle, Thomas Roth, et al.
Experimental and Clinical Psychopharmacology
|
August 11, 2004
Reinforcing and subjective effects of methylphenidate: dose and time in bed
Timothy Roehrs, Chris Ellyn Johanson, Renata Meixner, et al.
Sleep
|
February 3, 2011
Twelve months of nightly zolpidem does not lead to dose escalation: a prospective placebo-controlled study
Timothy A Roehrs, Surilla Randall, Erica Harris, et al.
Sleep Health
|
October 27, 2017
Sleep maintenance difficulties in insomnia are associated with increased incidence of hypertension
Philip Cheng, Vivek Pillai, Heather Mengel, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine
|
October 9, 2015
Post Hoc Analysis of Data from Two Clinical Trials Evaluating the Minimal Clinically Important Change in International Restless Legs Syndrome Sum Score in Patients with Restless Legs Syndrome (Willis-Ekbom Disease)
William G Ondo, Frank Grieger, Kimberly Moran, et al.
Human Psychopharmacology
|
October 31, 2002
Dose-response effects of zaleplon as compared with triazolam (0.25 mg) and placebo in chronic primary insomnia
Christopher L Drake, Timothy A Roehrs, Richard M Mangano, et al.
Page
of 40
Search research articles
Search
Showing results (151-160 of 396) with videos related to
Sort By:
Page
of 40
Human Psychopharmacology
|
October 2, 2007
Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrate
Thomas Roth, David Mayleben, Bruce C Corser, et al.
Sleep
|
December 2, 2011
Continuous positive airway pressure in severe obstructive sleep apnea reduces pain sensitivity
Imran Khalid, Timothy A Roehrs, David W Hudgel, et al.
The Clinical Journal of Pain
|
June 3, 2015
Pregabalin Improves Fibromyalgia-related Sleep Disturbance
Thomas Roth, Pritha Bhadra-Brown, Verne W Pitman, et al.
Human Psychopharmacology
|
December 15, 2019
Efficacy of SM-1 in a transient insomnia model
Thomas Dahl, Lan Bo Chen, Gary Zammit, et al.
Journal of Clinical Medicine
|
May 30, 2019
Sleep after Heavy Alcohol Consumption and Physical Activity Levels during Alcohol Hangover
Lydia E Devenney, Kieran B Coyle, Thomas Roth, et al.
Experimental and Clinical Psychopharmacology
|
August 11, 2004
Reinforcing and subjective effects of methylphenidate: dose and time in bed
Timothy Roehrs, Chris Ellyn Johanson, Renata Meixner, et al.
Sleep
|
February 3, 2011
Twelve months of nightly zolpidem does not lead to dose escalation: a prospective placebo-controlled study
Timothy A Roehrs, Surilla Randall, Erica Harris, et al.
Sleep Health
|
October 27, 2017
Sleep maintenance difficulties in insomnia are associated with increased incidence of hypertension
Philip Cheng, Vivek Pillai, Heather Mengel, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine
|
October 9, 2015
Post Hoc Analysis of Data from Two Clinical Trials Evaluating the Minimal Clinically Important Change in International Restless Legs Syndrome Sum Score in Patients with Restless Legs Syndrome (Willis-Ekbom Disease)
William G Ondo, Frank Grieger, Kimberly Moran, et al.
Human Psychopharmacology
|
October 31, 2002
Dose-response effects of zaleplon as compared with triazolam (0.25 mg) and placebo in chronic primary insomnia
Christopher L Drake, Timothy A Roehrs, Richard M Mangano, et al.
Page
of 40